News & Media
It’s been said that it is hard to raise awareness of pancreatic cancer because people who get it don’t live long enough. Creating awareness and informing the public about pancreatic cancer is paramount to making real change happen. We are committed to raising our voices on behalf of those who can’t.
Newsletters
Join TheFight By
Signing Up Today!
Archive
In The News
Drug That Gives Pancreatic Cancer Patients More Time is Out of Reach
Drug That Could Give Pancreatic Cancer Patients More Time is Out of Reach: Healthing.comPCC CEO Michelle Capobianco, pancreatic cancer researchers and patient advocates question the pan-Canadian Pharmaceutical Alliance (pCPA) delaying the funding of pancreatic cancer...
read moreAccess to Pancreatic Cancer Treatments Newstalk 1010
Access to Pancreatic Cancer Treatments: Pancreatic Cancer Canada CEO Michelle Capobianco Speaks to Newstalk 1010 Michelle Capobianco, Chief Executive Officer of Pancreatic Cancer Canada, speaks with John Moore of Newstalk 1010 about the bureaucracy that prevents new...
read morePromising Treatment for Deadly Cancer Blocked by Canadian Regulators
Promising Treatment for Deadly Cancer Blocked by Canadian Regulators TORONTO, Aug. 19, 2020 /CNW Telbec/ - While innovations in health care are spurring extraordinary advances in the treatment of malignant tumours, progress has been limited when it comes to the...
read more
Spotlight: Pam Kosolofski
Community fundraiser adapts amidst global pandemic Dedicated. Resilient. Compassionate. These are just a few words that describe Pam Kosolofski, a steadfast champion of progress for pancreatic cancer patients – even amidst a global pandemic. Each spring, Pam organizes...
read more
NeoPancONE Announcement: A Message from Michelle Capobianco
For several months the COVID-19 crisis has caused many research projects to slow, but Pancreatic Cancer Canada's research program has not been idle. We have taken this time to quietly prepare for our next big project, because even in the midst of a...
read more
PRESS RELEASE: NeoPancONE Clinical Trial Launch
Pancreatic Cancer Clinical Trial Launches During Pandemic With Aim to Change Standard of Care for Patients TORONTO, ON, July 15, 2020 – Pancreatic Cancer Canada announced today the launch of NeoPancONE, a Phase II clinical trial that aims to be a curative strategy for...
read moreFOLLOW US
FOR MEDIA INQUIRIES
Amanda Jodoin
Director, Marketing and Communications
ajodoin@pccf.ca
416-548-8077 ext 1006
Join The
Fight By
Signing
Up Today!
316-4211 Yonge Street
Toronto, ON M2P 2A9
Toll Free: 1-888-726-2269
info@pccf.ca
Charitable Registration Number 84870 1967 RR0001